NR2C2 and central nervous system cancer: CCK-8 assay was conducted and revealed the increase of proliferation of glioma cells in NR2C2(+) group (P < 0.01), and the decrease in NR2C2(−) group compared with the NC group (Fig. 3d, P < 0.01).